BT-001
DM2-07-CAT
Phase 3 other terminated
Quick answer
BT-001 for Type2 Diabetes is a Phase 3 program (other) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Type2 Diabetes
- Phase
- Phase 3
- Modality
- other
- Status
- terminated